Roles
- Professor of Clinical Medicine
-
Biography
Professor of Clinical Medicine at the University of Miami School of Medicine, Miami, Florida, USA. Received both his bachelor’s degree in biology and medical degree from the Universidad Peruana Cayetano Heredia, Lima, Peru in 1994 and completed his training in Internal Medicine, Critical Care Medicine and Pulmonary Medicine at the University of Miami/Jackson Memorial Medical Center, Miami, Florida. In 2003 joined the faculty at the University of Miami School of Medicine. In addition to his academic career, has worked as Section Chief, Pulmonary Medicine of the Miami Veterans Administration Medical Center, Miami, Florida. -
Education & Training
Education
Post Graduate Training
Licensures and Certifications
-
Honors & Awards
-
Teaching Interests
Bedside clinical teaching -
Research Interests
Principal investigator in many research trials focusing in tobacco smoking, electronic cigarettes and COPD. Particular interest in alpha-1 antitrypsin deficiency (AATD), and have performed trials sponsored by NIH, the Alpha-1 Foundation and Industry. Particular interests focus in bronchial epithelial alpha-1 antitrypsin, the role of AAT in inflammation, the microbiome, the effects of double dose augmentation therapy and the long-term outcomes of patients with AATD, clinical outcomes in COPD -
Publications
Disclaimer: Information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, use this link to inform our data team. Your feedback is appreciated and helps us improve the quality of our content.Professional Activities
Clinical Trials
Viewing 0 of 4 clinical trials.
-
A Multi-Center, Single-Dose and Repeat-Dose Over Eight Weeks, Sequential Cohort Study to Evaluate Safety and Tolerability as Well as Pharmacokinetics of Two Different Doses of Alpha1-Proteinase Inhibitor Subcutaneous (Human) 15% Administered Subcutaneously in Subjects With Alpha1-Antitrypsin Deficiency
- Principal Investigator: Michael Campos
- Study Phase: Phase 1/Phase 2
- Enrollment Status: Closed
-
An Open-Label, Multicenter, Phase 1 Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Ascending Intravenous Doses of Inhibrx rhAAT-Fc (INBRX-101) in Adults With Alpha-1 Antitrypsin Deficiency (AATD)
- Principal Investigator: Michael Campos
- Study Phase: Phase 1
- Enrollment Status: Not Accepting
-
A Multi-Center, Single-Dose and Repeat-Dose Over Eight Weeks, Sequential Cohort Study to Evaluate Safety and Tolerability as Well as Pharmacokinetics of Two Different Doses of Alpha1-Proteinase Inhibitor Subcutaneous (Human) 15% Administered Subcutaneously in Subjects With Alpha1-Antitrypsin Deficiency
- Principal Investigator: Michael Campos
- Study Phase: Phase 1/Phase 2
- Enrollment Status: Closed
-
An Open-Label, Multicenter, Phase 1 Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Ascending Intravenous Doses of Inhibrx rhAAT-Fc (INBRX-101) in Adults With Alpha-1 Antitrypsin Deficiency (AATD)
- Principal Investigator: Michael Campos
- Study Phase: Phase 1
- Enrollment Status: Not Accepting